Mitsui Global Investment — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
ArmaGenFeb 2018Acquired
ArmaGen develops blood-brain-barrier-crossing protein therapies for lysosomal storage disorders; acquired by JCR Pharmaceuticals in 2020.
BiotechCalabasas, US
Ruben Boado(Executive Officer)William Pardridge(Director)Mathias Schmidt(Executive Officer, Director)
BoardJayson Punwani(Director)Martin Heidecker(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.